Stock exchanges & markets

Overview Watchlists

Newron reports investor group subscribes to 433,070 new shares for EUR 5.5 million in private placement

8. Sep 2026

(AWP Alliance News) - Newron Pharmaceuticals reported that an investor group subscribed to a second tranche of 433,070 newly issued shares for gross proceeds of EUR 5.5 million under a financing agreed in February 2026. The funding forms part of up to EUR 38 million in total proceeds tied to progress in the ENIGMA-TRS Phase 3 program for evenamide. A third EUR 5.5 million tranche is expected by Nov. 30, 2026. A further EUR 12 million investment is contingent on positive ENIGMA-TRS results.

https://www.publicnow.com/view/CDDDF58D54B48A38A9B36062950E6B532E260578…

Disclaimer: This news brief was created using generative artificial intelligence. Newron Pharmaceuticals S.p.A. published the original content used to generate this news brief via EQS News on September 08, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now